ClinicalTrials.gov record
Improving Physical Ability and Cellular Senescence Elimination in HIV
ClinicalTrials.gov ID: NCT07144293
Public ClinicalTrials.gov record NCT07144293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 20, 2026, 1:15 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07144293
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Interventions
- Dasatinib Drug
- Placebo - Dasatinib Other
- Placebo - Quercetin Other
- Quercetin Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2025
- Primary completion
- Nov 28, 2026
- Completion
- Nov 28, 2026
- Last update posted
- May 18, 2026
2025 – 2026
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles CARE Center CRS (Site ID: 601) | Los Angeles | California | 90035-4709 | — |
| UCSD Antiviral Research Center CRS (Site ID: 701) | San Diego | California | 92103 | — |
| University of California, San Francisco HIV/AIDS CRS (Site ID: 801) | San Francisco | California | 94143 | — |
| Harbor University of California Los Angeles Center CRS (Site ID: 603) | Torrance | California | 90502 | — |
| University of Colorado Hospital CRS (Site ID: 6101) | Aurora | Colorado | 80045 | — |
| Whitman-Walker Institute, Inc. CRS (Site ID: 31791) | Washington D.C. | District of Columbia | 20009 | — |
| The Ponce de Leon Center CRS (Site ID: 5802) | Atlanta | Georgia | 30308-2012 | — |
| Northwestern University CRS (Site ID: 2701) | Chicago | Illinois | 60611 | — |
| Massachusetts General Hospital CRS (MGH CRS) (Site ID: 101) | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS (Site ID: 107) | Boston | Massachusetts | 02115 | — |
| Washington University Therapeutics (WT) CRS (Site ID: 2101) | St Louis | Missouri | 63110-1010 | — |
| New Jersey Medical School Clinical Research Center CRS (Site ID: 31786) | Newark | New Jersey | 07103 | — |
| Weill Cornell Chelsea CRS (Site ID: 7804) | New York | New York | 10010 | — |
| Columbia Physicians & Surgeons (P&S) CRS (Site ID: 30329) | New York | New York | 10032 | — |
| Weill Cornell Uptown CRS (Site ID: 7803) | New York | New York | 10065 | — |
| University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site ID: 31787) | Rochester | New York | 14642 | — |
| Chapel Hill CRS (Site ID: 3201) | Chapel Hill | North Carolina | 27599 | — |
| Greensboro CRS (Site ID: 3203) | Greensboro | North Carolina | 27401 | — |
| Cincinnati CRS (Site ID: 2401) | Cincinnati | Ohio | 45267-0405 | — |
| Case CRS (Site ID: 2501) | Cleveland | Ohio | 44106 | — |
| Ohio State University CRS (Site ID: 2301) | Columbus | Ohio | 43210 | — |
| Penn Therapeutics CRS (Site ID: 6201) | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh CRS (Site ID: 1001) | Pittsburgh | Pennsylvania | 15213 | — |
| Vanderbilt Therapeutics (VT) CRS (Site ID: 3652) | Nashville | Tennessee | 37204 | — |
| Houston Advancing Research Team CRS (Site ID: 31473) | Houston | Texas | 77030 | — |
| University of Washington Positive Research CRS (Site ID: 1401) | Seattle | Washington | 98104-9929 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07144293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07144293 live on ClinicalTrials.gov.